The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis | Zendy

Valeria Fabre | Zendy; Koorosh Nemati | Zendy; Edina Avdic | Zendy; Sara E. Cosgrove | Zendy; Joe Amoah | Zendy; Pranita D. Tamma | Zendy

Open Access

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis

Author(s) -

Valeria Fabre,

Koorosh Nemati,

Edina Avdic,

Sara E. Cosgrove,

Joe Amoah,

Pranita D. Tamma

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy339

Subject(s) - ertapenem , enterococcus faecalis , medicine , piperacillin/tazobactam , enterococcus , piperacillin , tazobactam , microbiology and biotechnology , gram positive bacterial infections , meropenem , antibiotics , bacteria , imipenem , staphylococcus aureus , antibiotic resistance , genetics , pseudomonas aeruginosa , biology

Controversy remains as to whether recovered from intra-abdominal infections (IAIs) requires targeted therapy. In a multicenter study comparing patients with IAIs from which was identified in intra-abdominal cultures, no difference in clinical outcomes was observed between patients receiving ertapenem vs those receiving piperacillin/tazobactam.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research